Mr. Speaker, I rose in the House recently to ask a question concerning silicone gel breast implants. Unfortunately, the answer that I got did not satisfy me. I will thus try to get a better one today.
It has been brought to my attention that the medical devices special access program, intended for serious, dangerous or even deadly diseases, has been used excessively to allow surgeons to procure silicone gel breast implants. Thus, they can carry out breast augmentations, replacements following implant rupture, or breast reconstructions.
These silicone gel implants have not been approved by Health Canada. These are the third generation of silicone gel implants. We have experienced major problems with the other two generations. It has not been proven in any way that implants from this new generation are safe or harmless for women.
I am worried because Health Canada has taken a rather lax attitude with respect to the distribution of such breast implants. It is actually moving toward a culture of acceptable risk. Surgeons are being allowed to procure and use breast implants that have not even been approved. In the 1990s, their use was denounced, and it was demanded that production be stopped. Today, surgeons are nevertheless allowed, for very unconvincing reasons, to be supplied with breast implants filled with silicone gel whose long term effects are unknown.
Unfortunately, in previous years we saw that the long term effects could be disastrous. We have seen that approximately 70% of women who undergo breast augmentation using silicone gel implants experience serious problems, including implant rupture as well as capsular contracture. Women experience all sorts of very serious problems because of these implants.
There is one thing I am having more and more of a problem with, and I am realizing it today. The initial surgery is elective surgery and, as such, is paid for by the client. However, subsequent surgeries to remove a breast implant or treat a patient are at public expense. As we know, the health system is seriously overloaded at present and it cannot absorb additional costs. In addition, these companies do not produce comprehensive reports or studies on the safety of these implants.
I would like the parliamentary secretary to tell me something. When the program was established in 1993, there were 17 requests granted every year at first. That was not very many, and it was mainly for the purpose of reconstruction. It continued until 1997. In 1997 and 1998, approval for the use of these implants was totally discontinued because, at the time, class action suits were likely to be won. Now, the number of requests sought and granted has grown to 6,211 a year. In 2004 alone, the use of 6,211 silicone gel breast implants was authorized. I find all that very unfortunate and worrisome. I would like to know why this is happening.